Industrie: Evonik-Chef Kullmann erkrankt – Rettig wird Interims-CEO
Wegen einer überraschenden Operation scheidet Kullmann kurzfristig von der Evonik-Spitze. Der aktuelle Asien-Chef übernimmt, Kullmann soll aber zurückkehren.
Christian Kullmann, the CEO of Evonik, has fallen temporarily ill due to a surprise operation. The 57-year-old has since been in rehabilitation, with Evonik not providing a timeline for his return. In response, the company chose an interim solution for the leadership of the chemical group. As interim CEO, Claus Rettig, the Asia chief of Evonik, was appointed.
The 66-year-old will become a board member and deputy CEO. Rettig has been with the company, and its predecessor, for 30 years. He served as interim finance chief between September 2025 and May 2026 when the then CFO, Maike Schuh, resigned by her own request. The head of the supervisory board, Bernd Tönjes, expressed relief that Kullmann survived the operation well and wishes him a speedy recovery.
He stated, "We are all glad and relieved that Christian Kullmann has survived his operation. We sincerely wish him a good recovery. We firmly expect that he will resume his duties after rehabilitation."
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
